Ying Li

Biparatopic antibody BA7208/7125 effectively neutralizes SARS-CoV-2 variants including Omicron BA.1-BA.5

G. Du, Jincun Zhao, Ruxi Qi, 2023, Cell Discovery.

Preclinical Evaluation of IMGC936, a Next Generation Maytansinoid-based Antibody-drug Conjugate Targeting ADAM9-expressing Tumors.

A. Dastur, P. Moore, T. Chittenden, 2022, Molecular cancer therapeutics.

Two novel human anti-CD25 antibodies with antitumor activity inversely related to their affinity and in vitro activity

C. Dou, Hong Liu, Chunjie Sha, 2021, Scientific Reports.

Structure and function analysis of a potent human neutralizing antibody CA521LALA against SARS-CoV-2

G. Du, Jingwei Tian, Yongqiang Deng, 2021 .

Structure and function analysis of a potent human neutralizing antibody CA521FALA against SARS-CoV-2

G. Du, Jingwei Tian, Yongqiang Deng, 2021, Communications biology.

hACE2 Fc-neutralization antibody cocktail provides synergistic protection against SARS-CoV-2 and its spike RBD variants

Yongqiang Deng, C. Qin, Qi Chen, 2021, Cell discovery.

Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape

Hao Song, Y. Chai, Qihui Wang, 2022, Nature Communications.